Close

CoLucid Pharmaceuticals (CLCD) Offers Interim Update on Lasmiditan Phase 3

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. META
3. ENPH
4. TXN
5. BA
6. SPOT
7. IBM
8. V
9. HCP
10. CMG


Go back to CoLucid Pharmaceuticals (CLCD) Offers Interim Update on Lasmiditan Phase 3
(NASDAQ: CLCD) Delayed: 46.53 --0 (-0%)
Previous Close $46.53    52 Week High $39.27 
Open $0.21    52 Week Low $4.30 
Day High $46.53    P/E N/A 
Day Low $46.53    EPS $0.00 
Volume 3,282